P
Phyllis August
Researcher at Cornell University
Publications - 111
Citations - 9618
Phyllis August is an academic researcher from Cornell University. The author has contributed to research in topics: Pregnancy & Preeclampsia. The author has an hindex of 35, co-authored 106 publications receiving 8520 citations. Previous affiliations of Phyllis August include New York Hospital Queens & NewYork–Presbyterian Hospital.
Papers
More filters
Journal ArticleDOI
Hypertension in pregnancy: Executive summary
James M. Roberts,Phyllis August,George Bakris,John R. Barton,Ira M. Bernstein,Maurice L. Druzin,Robert R. Gaiser,Joey P. Granger,Arun Jeyabalan,Donna D. Johnson,S. Ananth Karumanchi,Marshall D. Lindheimer,Michelle Y. Owens,Geroge R. Saade,Bahaeddine M Sibai,Catherine Y. Spong,Eleni Tsigas,Gerald E. Joseph,Nancy O'Reilly,Alyssa Politzer,Sarah Son,Karina Ngaiza +21 more
Journal ArticleDOI
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
L. Frye,Phyllis August,Regina M. Hardi,Sheryl F. Kelsey,Trevor J. Orchard,Bernard R. Chaitman +5 more
TL;DR: Overall, there was no significant difference in the rates of death and major cardiovascular events between patients undergoing prompt revascularization and those undergoing medical therapy or between strategies of insulin sensitization and insulin provision.
Journal ArticleDOI
Urinary-Cell mRNA Profile and Acute Cellular Rejection in Kidney Allografts
Manikkam Suthanthiran,Joseph E. Schwartz,Ruchuang Ding,Michael Abecassis,Darshana Dadhania,Benjamin Samstein,Stuart J. Knechtle,John J. Friedewald,Yolanda T. Becker,Vijay K. Sharma,N. Williams,C. Chang,Christine Hoang,Thangamani Muthukumar,Phyllis August,Karen Keslar,Robert L. Fairchild,Donald E. Hricik,Peter S. Heeger,Leiya Han,Jun Liu,Michael Riggs,David Ikle,Nancy D. Bridges,Abraham Shaked +24 more
TL;DR: A molecular signature of CD3ε mRNA, IP-10 mRNA, and 18S rRNA levels in urinary cells appears to be diagnostic and prognostic of acute cellular rejection in kidney allografts.
Journal ArticleDOI
Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage.
Manikkam Suthanthiran,Baogui Li,Jong O. Song,Ruchuang Ding,Vivek Sharma,Joseph E. Schwartz,Phyllis August +6 more
TL;DR: The findings support the idea that TGF-β1 hyperexpression is a risk factor for hypertension and hypertensive complications and provides a mechanism for the excess burden of hypertension in blacks.
Journal ArticleDOI
Update on the Use of Antihypertensive Drugs in Pregnancy
Tiina Podymow,Phyllis August +1 more
TL;DR: The focus of treatment is the 9 months of pregnancy, during which untreated mild-to-moderate hypertension is unlikely to lead to unfavorable long-term maternal outcomes, and antihypertensive agents are mainly used to prevent and treat severe hypertension.